Clinical trial Recruiting at 1 site Observational Ages 2 Months to 11 Months

Baby brain MRI during natural sleep to track early development and cerebral palsy risk

Official title: Neuroimaging of Babies During Natural Sleep to Assess Typical Development and Cerebral Palsy

Run by Danish Research Centre for Magnetic Resonance · NCT06396520 · Data updated 2026-11-12

We will try advanced MRI scans while infants sleep naturally to see if they reveal early brain differences in babies at risk for cerebral palsy and in typically developing infants.

More Cerebral Palsy trials

Quick facts

Study typeObservational
Ages2 Months to 11 Months
SexAll
Enrollment200 (estimated)
SponsorDanish Research Centre for Magnetic Resonance
Academic / other
Locations1 site (Hvidovre, Capital Region)
StatusRecruiting
StartedJune 1, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJanuary 28, 2026
Trial IDNCT06396520 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are infants aged about 3–24 months who are either at increased risk for cerebral palsy (for example very preterm birth, very low birthweight, moderate–severe neonatal brain injury, or early motor asymmetry/failure to sit) or typically developing infants for comparison, and who can tolerate MRI during natural sleep and attend longitudinal visits in Denmark.

Probably not a fit

Infants with contraindications to MRI (for example implanted metal devices), unstable medical conditions, those outside the 3–24 month window, or families unable to travel to the Danish imaging site are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a longitudinal observational cohort that will enroll about 200 infants (at-risk and typically developing) and follow them across three visits between roughly 3 months and 2 years of age. Participants will undergo 3 Tesla MRI during natural sleep using advanced sequences, including diffusion-weighted imaging, alongside standardized motor and cognitive assessments. The study includes infants recruited from a linked CP-EDIT cohort and local Danish clinical sites and collects imaging and parent-reported measures but no interventions. The goal is to map how early brain imaging markers relate to later motor and cognitive development and to refine procedures for clinical infant MRI during natural sleep.

Why it matters

Potential benefit: If successful, the approach could enable earlier and more sensitive detection of brain injury related to cerebral palsy, allowing earlier targeted intervention during a high-plasticity window.

How similar studies have gone: Conventional structural neonatal MRI and some diffusion MRI studies have previously helped identify brain injury related to CP, but the use of advanced diffusion sequences during natural sleep in a longitudinal infant cohort is relatively novel and less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria High-Risk population:

Group: 'Newborn-detectable risk-pathway'

* Preterm birth with gestational age below 32 weeks
* Birth weight below 1500 g
* Moderate to severe brain injury (A label of moderate to severe brain injury was considered if there was Papile grade three to four intraventricular haemorrhage, cystic periventricular leukomalacia, neonatal stroke, term hypoxic-ischaemic encephalopathy (≥35 weeks gestation at birth) or other significant neurological condition)
* History (e.g., neonatal seizures, ECMO, meningitis, kernicterus, severe hypoglycemia) or neurological risk factors (malformations in CNS, increased tone)

Group: 'Infant detectable risk-pathway'

* Inability to sit independently by age 9 months
* Hand function asymmetry or crawl asymmetry
* Inability to take weight through the plantar surface of the feet
* History (e.g., as above) or neurological risk factors

Additional inclusion criteria for inclusion in NIBS-CP for both CP-risk groups:

\- Consent to health-relevant information on clinical findings being passed on to the medical doctors in CP-EDIT and/or their primary care physician.

Inclusion Criteria Typically developing infant population:

* Born \>37 weeks
* Uneventful birth
* No known history of brain injury
* No neurological condition
* Consent to health-relevant information on clinical findings being passed on to their primary care physician or relevant medical doctors, e.g., neuropaediatrician.

Exclusion Criteria (all groups):

* Infants have any MRI contraindications, e.g., pacemaker or other implanted electronic devices.
* Families do not speak or understand Danish.
* Families do not wish to be informed about incidental findings on the MRI, or scores within the clinical range in the neurological, motor, or cognitive assessments.

Where it's running

  • Danish Research Centre for Magnetic Resonance
    Hvidovre, Capital Region, Denmark
    Recruiting

Study contacts

  • Principal investigator: Kathrine Skak Madsen, PhD — Senior Researcher
  • Study coordinator: Line K Johnsen, PhD
  • Email: linekj@drcmr.dk
  • Phone: +4561145571

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.